Connect with us

Published

5 months ago

on

Jaap Arriens | Nurphoto | Getty Images

The U.K.’s competition watchdog has opened an initial review into Microsoft’s mammoth investment into ChatGPT-creator OpenAI, making it the first major regulator to flag potential competition concerns over the tech giant’s relationship with one of the most important AI companies today.

The Competition and Markets Authority said in a statement Friday that it is seeking views from interested parties to address whether Microsoft’s $10 billion investment in OpenAI has led to a “relevant merger situation,” where two or more businesses have ceased or will cease to be distinct as a result of a transaction.

The CMA said the pace at which AI is scaling is “unrivalled in economic history,” and that advances in so-called foundation models, which describe general purpose AI tools such as ChatGPT, represent a “pivotal moment in the development of this transformative technology.”

The regulator said it will review whether Microsoft’s partnership with OpenAI has resulted in an acquisition of control – in other words, a situation where one company has material influence, de facto control, or more than 50% of the voting rights over another entity.

“The invitation to comment is the first part of the CMA’s information gathering process and comes in advance of launching any phase 1 investigation, which would only happen once the CMA has received the information it needs from the partnership parties,” Sorcha O’Carroll, senior director for mergers at the CMA, said in a statement.

Microsoft President and Vice Chair Brad Smith, responding to the CMA’s statement, called out Google’s 2014 acquisition of British AI lab DeepMind, saying that Microsoft’s partnership with OpenAI is unlike that deal.

“Since 2019, we’ve forged a partnership with OpenAI that has fostered more AI innovation and competition, while preserving independence for both companies,” Microsoft’s Smith said in the statement Friday.

“The only thing that has changed is that Microsoft will now have a non-voting observer on OpenAI’s Board, which is very different from an acquisition such as Google’s purchase of DeepMind in the UK. We will work closely with the CMA to provide all the information it needs.”

Separately, the CMA is reviewing the AI industry to assess what risks and opportunities foundation models present, and what principles need to be applied to the tech to prevent competition and consumer protection breaches. The European Union is also expected to agree on landmark rules designed to regulate AI technology later Friday.

Related Topics:
Continue Reading

Technology

Microsoft announces new PCs with AI chips from Qualcomm

Published

3 hours ago

on

May 20, 2024

By

Microsoft announces new PCs with AI chips from Qualcomm

Microsoft Chairman and Chief Executive Officer Satya Nadella speaks during the Microsoft May 20 Briefing event at Microsoft in Redmond, Washington, on May 20, 2024. 

Jason Redmond | AFP | Getty Images

Microsoft is touting new computers with advanced chips designed to run artificial intelligence features of software for Windows, without quickly using up battery life.

The company on Monday announced a Surface Laptop and a Surface Pro tablet with a Qualcomm chip that can run some AI tasks without an internet connection. Other computer makers like Lenovo, Dell, HP, Asus, Acer and Samsung are also launching AI-ready PCs powered by Qualcomm’s Snapdragon X Elite and X Plus processors, which promise longer battery life and will run Microsoft’s Copilot AI chatbot.

Device makers will release PCs with AMD and Intel chips that will adhere to the Copilot+ standard at a later time, Microsoft said during a press keynote address on its campus in Redmond, Washington. The PCs will be able to translate audio, recommend responses to incoming messages and suggest changes in the Settings app, and even talk with people about what’s on screen.

Copilot+ PCs will start at $999. Microsoft is accepting pre-orders as of Monday, and the devices will become available in June.

A Recall feature will be able to search through a log of previous actions on PCs. Recall relies on AI models that run directly on the device, so it can run offline, and an index of the data never goes to remote servers. AI models will be able to generate images based on written descriptions as well as drawings.

Microsoft is banking on Qualcomm’s energy-efficient Arm-based chips that can handle AI models to defend its Windows franchise. Apple has gained market share in PC shipments with MacBooks containing its Arm-based chips, having moved away from Intel, the top provider of computer processors.

Microsoft is expanding its effort to surround consumers and business users with ChatGPT-like capabilities. OpenAI, backed by Microsoft, released the ChatGPT chatbot in late 2022, and it took off as a tool for quickly obtaining computer-generated poems, email drafts and summaries of historical events.

Other large technology companies, including Microsoft, soon started augmenting their products with generative AI. A Copilot chatbot drawing on ChatGPT’s underlying AI models came to the Bing search engine, along with the Windows 10 and 11 operating systems. Those with Office productivity software subscriptions could pay extra to have a Copilot refer to their documents for written responses.

The GPT-4 model inside ChatGPT has only done its necessary computing work in Microsoft’s Azure cloud. The new PCs can run some AI models locally without an internet connection.

The launch comes nearly four months after Microsoft CEO Satya Nadella told analysts on the company’s earnings call that “in 2024, AI will become a first-class part of every PC.”

Microsoft has had little success in getting people to adopt Arm-based Windows computers, which haven’t always performed as well as PCs running Intel or AMD chips. Certain applications have been incompatible.

Running generative AI locally means computers will need more power, and strong battery life becomes more critical. That might make Windows on Arm more compelling.

Analysts with Morgan Stanley expect Arm systems to be 14% of all Windows PC shipments in 2026, up from 0% in 2023, according to a note distributed to clients earlier this month.

Microsoft shares closed up 1.2% Monday afternoon to $425.34, just shy of a record reached in March. Qualcomm rose 2% to $197.76 for a record close.

Don’t miss these exclusives from CNBC PRO

AI PC race speeds up ahead of significant chip launches

Continue Reading

Technology

With JPMorgan, Mastercard on board in biometric ‘breakthrough’ year, you may soon start paying with your face

Published

7 hours ago

on

May 20, 2024

By

With JPMorgan, Mastercard on board in biometric 'breakthrough' year, you may soon start paying with your face

Automated fast food restaurant CaliExpress by Flippy, in Pasadena, Calif., opened in January to considerable hype due to its robot burger makers, but the restaurant launched with another, less heralded innovation: the ability to pay for your meal with your face.

CaliExpress uses a payment system from facial ID tech company PopID. To activate it, users register with a selfie. Then they can opt to be recognized and then PopID’s facial verification confirms the transaction.

It’s not the only fast-food chain to employ the technology. In January, Steak ‘N Shake, a fast-casual restaurant in the Midwest, started installing facial recognition kiosks in its 300 locations for patron check-in. The chain says that using PopID takes two to three seconds compared with a check-in with a QR code or mobile app, which can take up to 20 seconds.

Biometric payment options are becoming more common. Amazon introduced pay-by-palm technology in 2020, and while its cashier-less store experiment has faltered, it installed the tech in 500 of its Whole Foods stores last year. Mastercard, which is working with PopID,  launched a pilot for face-based payments in Brazil back in 2022, and it was deemed a success — 76% of pilot participants said they would recommend the technology to a friend. Late last year, Mastercard said it was teaming with NEC to bring its Biometric Checkout Program to the Asia-Pacific region.

“Our focus on biometrics as a secure way to verify identity, replacing the password with the person, is at the heart of our efforts in this area,” said Dennis Gamiello, executive vice president of identity products and innovation at Mastercard. He added that based on positive feedback from the pilot and its research, the checkout technology will come to more new markets later this year.

As stores implement biometric technology for a variety of purposes, from payments to broader anti-theft systems, consumer blowback, and lawsuits, are rising. In March, an Illinois woman sued retailer Target for allegedly illegally collecting and storing her and other customers’ biometric data via facial recognition technology without their consent. Amazon and T-Mobile are also facing legal actions related to biometric technology.

In other countries, most notably China, biometric payment systems are comparatively mature, from visitors to McDonald’s in China being able to use facial recognition technology to pay for their orders, to systems offered by AliPay, which launched biometric payment as far back as 2015 and began testing the technology at KFC locations in China in 2018.

A deal that PopID recently signed with JPMorgan is a sign of things to come in the U.S., said John Miller, PopID CEO, and what he thinks will be a “breakthrough” year for pay-by-face technology.

The consumer case is tied to the growing importance of loyalty programs. Most quick-service restaurants require consumers to provide their loyalty information to earn rewards — which means pulling out a phone, opening an app, finding the link to the loyalty QR code, and then presenting the QR code to the cashier or reader. For payment, consumers are typically choosing between pulling out their wallet, selecting a credit card, and then dipping or tapping the card or pulling out their phone, opening it with Face ID, and then presenting it to the reader. Miller says PopID simplifies this process by requiring just tapping an on-screen button, and then looking briefly at a camera for both loyalty check-in and payment.

“We believe our partnership with JPMorgan is a watershed moment for biometric payments as it represents the first time a leading merchant acquirer has agreed to push biometric payments to its merchant customers,” Miller said. “JPMorgan brings the kind of credibility and assurance that both merchants and consumers need to adopt biometric payments.”

Consumers are getting more comfortable with biometric technology. The majority still prefer fingerprint scans to facial recognition, according to a 2023 survey from PYMENTS, but age is a factor. Gen Z consumers are more open to facial recognition than to fingerprint scans or entering a password.

Juniper Research forecasts over 100% market growth for global biometric payments between 2024 and 2028, and by 2025, $3 trillion in mobile, biometric-secured payments.

To be sure, security concerns and the hacking of biometric data as a consequence of sharing it, will remain important to the evolving usage and conversation.

Sheldon Jacobson, a professor in computer science at the University of Illinois, Urbana-Champaign, said he sees biometric identification as part of a technology continuum that has evolved from payment with a credit card to smartphones. “The next natural step is to simply use facial recognition,” he said.

Concerns about privacy and facial recognition, he says, are overblown. “We voluntarily give up our privacy all the time,” Jacobson said. “We post on Facebook, we use social media and we are basically giving up our privacy. I tell people constantly that everything about you is already out there.” 

Continue Reading

Technology

Shares of Hims & Hers Health surge 30% after startup says it will offer GLP-1 injections

Published

10 hours ago

on

May 20, 2024

By

Shares of Hims & Hers Health surge 30% after startup says it will offer GLP-1 injections

Products of Hims & Hers displayed.

Hims & Hers

Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday.

Shares of the company jumped more than 30% Monday morning.

The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December. But GLP-1 medications — such as Ozempic and Wegovy, which have skyrocketed in popularity — were not previously offered as part of that program.

Customers can access the compounded GLP-1 medications via a prescription from a licensed health-care provider on the Hims & Hers platform. Hims & Hers said it plans to make branded GLP-1 medications available to its customers once supply is consistently available.

The company’s oral medication kits start at $79 a month, and its compounded GLP-1 injections will start at $199 a month.

Even before it added compounded GLP-1s to its portfolio, Hims & Hers said in its fourth-quarter earnings report that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025. The company plans to offer updated guidance in its next earnings report.

The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced supply constraints in recent months as the drugs get expanded approval from health regulators and increased health coverage.

GLP-1s mimic a hormone produced in the gut to tamp down a person’s appetite and regulate their blood sugar. When those medications are in shortage, certain manufacturers can prepare a compounded version if they meet U.S. Food and Drug Administration requirements.

The FDA does not review the safety and efficacy of compounded products, which are custom-made alternatives to brand drugs designed to meet a specific patient’s needs.

In a January release, the FDA said patients should not use a compounded GLP-1 drug if an approved drug, such as Wegovy, is available.

Hims & Hers CEO Andrew Dudum told CNBC that the company is “confident” that customers will be able to access a consistent supply of the compounded medications.

Dudum said Hims & Hers has spent the last year learning about the GLP-1 supply chain and has partnered with one of the largest generic manufacturers in the country that has FDA oversight.

“We have a certain degree of exclusivity with that facility that will guarantee our consumers consistent volume and supply,” he said.

Don’t miss these exclusives from CNBC PRO

Continue Reading

Trending